Noam Tenne

Perineal tearing affects up to 90% of women birthing vaginally. It is painful and costly, estimated at over $10 billion annually in the US alone and for too long it has been accepted as an inevitable part of childbirth. We dont accept that. Peripear is developing a wearable medical device that translates an evidence-based midwifery intervention, warm compress application during the second stage of labour, into a consistent, hands-free clinical tool which is designed to reduce perineal tearing at the moment it most commonly occurs. We are backed by InnovateUK, 85% through our pre-seed round and in active conversation with US health systems about pilot partnerships. Our functional prototype is complete and was built in under two months. Behind Peripear are two founders with complementary depth. Nina brings 14 years of NHS and private midwifery practice with direct experience of the clinical gap this device is designed to address. Eviatar brings over a decade of healthtech leadership, having raised more than $75M and scaled MedTech companies from concept to market as CXO, supported by a PhD from the University of Cambridge and a visiting scholarship at MIT. We are building toward US hospital pilots, clinical evidence generation and long-term integration into standard perinatal care. If you are an investor, clinical innovator or health system leader who believes maternity care deserves better tools, wed always welcome a conversation.

Creds is a UK-based music tech startup making music licensing simple and scalable for the modern content world. Were building a platform that works for everyone involved in sync – artists, writers, publishers, labels, content creators and brands. By streamlining approvals and reducing back-and-forth, Creds helps unlock new revenue for rights holders and gives creators the clarity they need to licence music with confidence.

Personalised cancer therapeutics platform pioneered at Mount Sinai Medical Center

Après avoir découvert que les flashs UV-C augmentent la résistance des plantes face à divers pathogènes, les chercheurs Laurent Urban et Jawad Aarrouf déposent un premier brevet en 2015. Ils rencontrent alors Yves Matton, co-fondateur de Technofounders, avec qui ils s’associent et créent ensemble UV Boosting en 2016. Cette technologie innovante consiste à stimuler les défenses naturelles de la plante grâce aux flashs UV-C, provoquant le déclenchement d’un mécanisme de défense : la plante est ainsi plus résistante aux attaques de pathogènes ou aux stress abiotiques (gel, sécheresse...). Les équipements proposés ont divers avantages et permettent notamment une cadence de traitement flexible, s’adaptent à l’essentiel des engins agricoles standards et ne nécessitent pas de consommable. Alors que les restrictions règlementaires se font de plus en plus strictes ces dernières années, UV Boosting ambitionne de réduire considérablement la dépendance des producteurs aux fongicides et de les aider à résister au changement climatique, principalement sur les cultures de la vigne, de la fraise, des vergers et sur lentretien des gazons sportifs.

Scienta Lab is a deeptech company developing a unique and proprietary artificial intelligence technology to transform the drug discovery and development process in immunology and inflammation.

Sky Valley Ambient Computing is building infrastructure for adaptive software - software that is self-healing, personalized and generative in real time.

Perineal tearing affects up to 90% of women birthing vaginally. It is painful and costly, estimated at over $10 billion annually in the US alone and for too long it has been accepted as an inevitable part of childbirth. We dont accept that. Peripear is developing a wearable medical device that translates an evidence-based midwifery intervention, warm compress application during the second stage of labour, into a consistent, hands-free clinical tool which is designed to reduce perineal tearing at the moment it most commonly occurs. We are backed by InnovateUK, 85% through our pre-seed round and in active conversation with US health systems about pilot partnerships. Our functional prototype is complete and was built in under two months. Behind Peripear are two founders with complementary depth. Nina brings 14 years of NHS and private midwifery practice with direct experience of the clinical gap this device is designed to address. Eviatar brings over a decade of healthtech leadership, having raised more than $75M and scaled MedTech companies from concept to market as CXO, supported by a PhD from the University of Cambridge and a visiting scholarship at MIT. We are building toward US hospital pilots, clinical evidence generation and long-term integration into standard perinatal care. If you are an investor, clinical innovator or health system leader who believes maternity care deserves better tools, wed always welcome a conversation.

Creds is a UK-based music tech startup making music licensing simple and scalable for the modern content world. Were building a platform that works for everyone involved in sync – artists, writers, publishers, labels, content creators and brands. By streamlining approvals and reducing back-and-forth, Creds helps unlock new revenue for rights holders and gives creators the clarity they need to licence music with confidence.

Personalised cancer therapeutics platform pioneered at Mount Sinai Medical Center